Heroin Film
Early Stage
The fight for America's heart: a film on the opioid epidemic.
Analytics
Raised: $81,615
Aggregate Commitments $
Platform
Wefunder
Start Date
10/15/2018
Close Date
05/15/2019
Min. Goal
$50,000
Max. Goal
$107,000
Min. Investment
$250
Security Type
Revenue Share
Funding Type
RegCF
Rolling Commitments $
Status
Funded
Reporting Date
05/31/2019
Days Remaining
Funded
% of Min. Goal
163%
% of Max. Goal
76%
Likelihood of Max
Funded
Avg. Daily Raise
$385
# of Investors
78
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location
Morrisdale, Pennsylvania
Industry
Media, Entertainment & Publishing
Tech Sector
“Shooting Heroin” is a film about the fight for America’s heart. Focused on the opioid crisis and epidemic ravaging small-town America, this story focuses on a team of locals who form the first volunteer drug task force to confront the epidemic head-on, doing what’s necessary to protect their community. This will be one of the first films about the opioid epidemic, and the fourth feature film from director Spencer Folmar. His previous film was released in 22 countries, and its on track to pay investors back within one year of its release. Plus, this team has produced over 20 films combined, and they are in first look distribution deals with three distributors in Hollywood.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.